5473-13-2 Usage
Uses
Used in Organic Synthesis:
Ethyl 2,3-dicyano-3-phenylpropanoate is used as a precursor in the synthesis of various organic molecules for [application reason] its ability to undergo a wide range of chemical reactions.
Used in Pharmaceutical Research:
Ethyl 2,3-dicyano-3-phenylpropanoate is used as a building block in the design and development of new drugs and pharmaceuticals for [application reason] its potential in creating novel drug candidates.
Used in Chemical Reactions:
Ethyl 2,3-dicyano-3-phenylpropanoate is used as a versatile compound in the field of organic chemistry for [application reason] its ability to participate in various chemical reactions, contributing to the synthesis of complex organic molecules.
Check Digit Verification of cas no
The CAS Registry Mumber 5473-13-2 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,4,7 and 3 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 5473-13:
(6*5)+(5*4)+(4*7)+(3*3)+(2*1)+(1*3)=92
92 % 10 = 2
So 5473-13-2 is a valid CAS Registry Number.
5473-13-2Relevant academic research and scientific papers
Eco-friendly conjugate hydrocyanation of α-cyanoacrylates using potassium hexacyanoferrate(II) as cyanating reagent
Zhang, Yu-Peng,Hu, Xiao-Chun,Li, Zheng
, p. 596 - 603 (2015/04/14)
The conjugate hydrocyanation of α-cyanoacrylates through chemoselective 1,4-addition to synthesise α,β-dicyanopropanoates by one-pot two-step procedure using potassium hexacyanoferrate(II) as an eco-friendly cyanide source, benzoyl chloride as a promoter
Cyclopentane-based human NK1 antagonists. Part 1: Discovery and initial SAR
Finke, Paul E.,Meurer, Laura C.,Levorse, Dorothy A.,Mills, Sander G.,MacCoss, Malcolm,Sadowski, Sharon,Cascieri, Margaret A.,Tsao, Kwei-Lan,Chicchi, Gary G.,Metzger, Joseph M.,MacIntyre, D. Euan
, p. 4497 - 4503 (2007/10/03)
An initial investigation of the novel cyclopentane scaffold 6 afforded low nanomolar human NK1 antagonists having enhanced water solubility properties compared to morpholine 1. A synthesis of this cyclopentane scaffold, having three contiguous chiral cent
